Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
New Enterprise Associates
Biotech
Korro Bio rings in new year with $116M for OPERA RNA editing
Ticket sales for Korro Bio's second financing round landed at $116 million as the biotech builds up funds to bankroll its RNA editing platform.
Kyle LaHucik
Jan 5, 2022 7:30am
Gene therapy startup bursts forth from J&J and F-Prime incubator
Dec 3, 2021 8:25am
Music to its ears: Tune bags $40M to alter gene expression
Dec 2, 2021 6:00am
Shape Therapeutics reels in $112M to spur RNA editing tech
Jul 15, 2021 10:50am
MBX debuts with $35M to bankroll rare endocrine pipeline
Jul 27, 2020 8:00am
Mojo Vision sees $51M round for its smart contact lens
Apr 29, 2020 11:27am
